Key Metrics of MediWound Ltd.
Revenue$21.8M▲ 0.0% YoYFY 2020
Operating income−$8.8M▲ 0.0% YoY
Net profit−$9.2M▲ 0.0% YoY
Shareholders' equity$7.3M
Market cap$156MMDWD · $12.07
Competitors10identified
About MediWound Ltd.
Sectors
Company details
- Founded
- 2014
- Listed
- Nasdaq: MDWD (since 2014)
Operational Areas of MediWound Ltd.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameMediWound Ltd.
TickerMDWD
ExchangeNasdaq
CountryIsrael
SEC CIK0001593984
Listed since2014
Industry Medicinal Chemicals and Botanical Products
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
MDWD · Nasdaq · SEC CIK 0001593984
Last price · 28 Oct 2026
$12.07
+0.54%
Market cap$156M
P/E—On FY 2020 diluted EPS
Volume83,895
SectorHealth Care Medicinal Chemicals and Botanical Products
Country · IPOIsraelListed 2014
MDWD share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of MediWound Ltd.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.